Related Experiment Videos
Paying for blood donations: still a risk?
C L van der Poel1, E Seifried, W P Schaasberg
1Sanquin Blood Supply Foundation, Plesmanlaan 125, 1066 CX Amsterdam, the Netherlands. c_van_der_poel@sanquin.nl
Vox Sanguinis
|November 20, 2002
Summary
Paid blood donors continue to show higher rates of infectious disease markers compared to unpaid donors. This risk has not diminished over time, posing a continued concern for blood safety, especially for labile components.
Area of Science:
- Transfusion Medicine
- Infectious Disease Epidemiology
- Public Health
Background:
- The relevance of historical findings on increased infectious disease risk in paid blood donors is debated.
- Previous studies suggested higher infectious disease marker rates among paid donors, but trends over time are unclear.
Purpose of the Study:
- To assess whether the elevated risk of infectious disease markers in paid blood donors has changed over time.
- To evaluate the ongoing implications of donor selection on blood safety.
Main Methods:
- A meta-analysis of comparative studies published between 1968 and 2001 was conducted.
- Log-linear regression analysis was used to analyze relative risk estimates for infectious disease markers in paid versus unpaid donors from 28 datasets.
Main Results:
- Most studies, including recent ones, reported higher infectious disease marker rates in paid donors.
- Statistical analysis revealed no significant decrease in the risk difference between paid and unpaid donors over time (P = 0.128).
- Paid donors remain more likely to donate during the infectious "window period" and carry higher risks for labile blood components.
Conclusions:
- Paid blood donors continue to exhibit higher rates of infectious disease markers, indicating an ongoing risk.
- While plasma derivative processing may mitigate risks for plasma products, vigilance is needed for emerging infectious agents.
- Blood establishments should implement ongoing surveillance and report donor infectious disease marker data to authorities.